Dr Joseph Kang
Postdoctoral Scientist
Centre for Cancer Research
Hudson Institute of Medical Research
Australia
Biography
Dr Joseph Kang’s work within the Ovarian Cancer Biomarkers team at Hudson Institute is focused on accurately detecting and quantitating CXCL10 (a chemokine that is over-expressed in ovarian cancers) in biological fluids as a diagnostic indicator of ovarian cancer. Dr Kang’s research prior to joining Hudson Institute was to develop nanoparticle immunoassays in multiple formats as a diagnostic tool to monitor environmental contaminants.
Research Interest
The research focused on improving specificity and sensitivity of the assays through hapten design, antibody production, and nanoparticle-complex synthesis for industrial applications.
